GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: compound 18a5 [PMID: 40013713]
                                 
                                                         
                            Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Expression of annexin A3 (ANXA3) protein is elevated in a significant proportion of triple-negative breast cancer (TNBC) clinical samples, and this is associated with poor prognosis. This molecule behaves as a degrader of the ANXA3 protein, thus offering a novel mechanistic approach with therapeutic potential in TNBC [1].
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| References | 
| 
                                                                         1. Liu K, Zhu C, Liang Y, Min D, Jin Z, Sun X. (2025)
                                         Discovery of a Novel 1,4-Benzodiazepine Derivative as a Highly Selective ANXA3 Degrader for the Treatment of Triple-Negative Breast Cancer. J Med Chem, 68 (5): 5358-5381. [PMID:40013713]  |